Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.01%
1,089.49
-11.08
-1.01%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.21%
603.87
-1.28
-0.21%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.76
+19.57
+1.64%
1,195.191,204.711,217.721,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-1.45%
1,714.64
-25.27
-1.45%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.54%
642.01
+3.39
+0.54%
638.56640.21645.32639.66
SIXR
Staples
SIXR
Staples
SIXR
+1.34%
842.72
+11.15
+1.34%
831.57840.48843.98834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.73%
214.92
+1.56
+0.73%
213.36213.36215.54212.77
SIXT
Technology
SIXT
Technology
SIXT
-2.45%
3,154.91
-79.27
-2.45%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.37%
939.09
+3.44
+0.37%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.69%
1,459.31
+10.05
+0.69%
1,449.261,454.771,462.651,452.87
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.59%
2,368.36
-14.09
-0.59%
2,382.452,371.192,380.452,364.46
EVGN:NASDAQ
Evogene Ltd
$0.78
+0.18%
(+0.0014) 1D
Apr 28, 10:49:22 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVGN...
Open
$0.79
High
$0.79
Low
$0.78
Mkt. cap
6.81M
Avg. vol.
141.37K
Volume
2.16K
52-wk high
$2.42
52-wk low
$0.72
EPS
-$1.80
Beta
1.38
Shares outstanding
9.89M
No. of employees
52
News stories
From sources across the web
Profile
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
About Evogene Ltd
CEOOfer Haviv
Employees52
Founded1999
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.44M
884.00K
312.00K
314.00K
Cost of goods sold
1.61M
136.00K
157.00K
2.28M
Cost of revenue
1.61M
136.00K
157.00K
2.28M
Research and development expenses
3.21M
2.32M
1.38M
1.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.94M
1.50M
1.50M
1.20M
Operating expense
4.96M
3.82M
2.88M
3.00M
Total operating expenses
6.57M
3.96M
3.04M
5.28M
Operating income
-4.13M
-3.07M
-2.72M
-4.97M
Other non operating income
-
-
-
668.00K
EBT including unusual items
-2.99M
-4.68M
-2.73M
-5.34M
EBT excluding unusual items
-2.99M
-3.53M
-2.73M
-5.09M
Income tax expense
-
1.00K
1.00K
-
Effective tax rate
-
-0.02%
-0.04%
-
Other operating expenses
-191.00K
-
9.00K
-27.00K
Net income
-2.59M
-4.46M
3.87M
-5.31M
Net profit margin
-105.85%
-504.75%
1,241.67%
-1,690.76%
Earnings per share
-0.38
-0.50
-0.46
-0.62
Interest and investment income
1.60M
235.00K
465.00K
1.38M
Interest expense
-464.00K
-628.00K
-453.00K
-1.93M
Net interest expenses
1.14M
-393.00K
12.00K
-545.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.55M
-2.78M
-2.44M
-4.70M
Gain or loss from assets sale
-
-3.00K
12.00K
-27.00K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more